default author photo

Damian Starck

St. Vincent's Hospital - Molecular Diagnostic Medicine Laboratory

SCHOLARLY PAPERS

3

DOWNLOADS

330

TOTAL CITATIONS

5

Scholarly Papers (3)

1.

SARS-CoV-2 Omicron BA.5: Evolving Tropism and Evasion of Potent Humoral Responses and Resistance to Clinical Immunotherapeutics Relative to Viral Variants of Concern

Number of pages: 14 Posted: 11 Jul 2022
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, Government of New South Wales - Virology Research Laboratory, University of New South Wales (UNSW) - Kirby Institute, Royal Melbourne Institute of Technology (RMIT University) - School of Health and Biomedical Sciences, Royal Melbourne Institute of Technology (RMIT University) - School of Health and Biomedical Sciences, CSL Behring AG - Department of Bioanalytical Sciences, CSL Behring AG - Department of Bioanalytical Sciences, CSL Behring AG - Department of Bioanalytical Sciences, Government of New South Wales - Serology and Virology Division (SAViD), Government of New South Wales - Virology Research Laboratory, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, St. Vincent's Hospital, Royal Melbourne Institute of Technology (RMIT University) - School of Health and Biomedical Sciences, St. Vincent's Hospital - Molecular Diagnostic Medicine Laboratory, Garvan Institute of Medical Research, University of New South Wales (UNSW) - Kirby Institute, Government of New South Wales - Virology Research Laboratory, University of New South Wales (UNSW) - Kirby Institute and University of New South Wales (UNSW) - Kirby Institute
Downloads 137 (534,155)
Citation 4

Abstract:

Loading...

SARS CoV2 Variants, immunotherapeutics, ACE2, TMPRSS2, Omicron

2.

Cross-Sectional and Longitudinal Genotype to Phenotype Surveillance of SARS-CoV-2 Variants Over the First Four Years of the COVID-19 Pandemic

Number of pages: 28 Posted: 04 Jun 2024
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of Newcastle - Hunter Medical Research Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, The University of Sydney - Sydney Institute for Infectious Diseases, Government of New South Wales - Serology and Virology Division (SAViD), Government of New South Wales - Serology and Virology Division (SAViD), CSL Behring AG - Department of Bioanalytical Sciences, CSL Behring AG - Department of Bioanalytical Sciences, CSL Behring AG, CSL Behring AG, CSL Behring AG, CSL Behring AG, Government of New South Wales - Virology Research Laboratory, CSL Behring AG - Department of Bioanalytical Sciences, Karolinska Institutet, University of Newcastle (Australia) - Viral Immunology and Respiratory Disease Group, St. Vincent's Hospital, University of New South Wales (UNSW) - Kirby Institute, St. Vincent's Hospital - Molecular Diagnostic Medicine Laboratory, Histopath Diagnostic Specialists, Government of New South Wales - Virology Research Laboratory, Karolinska Institutet - Department of Microbiology, Tumor and Cell Biology (MTC), University of New South Wales (UNSW) - Kirby Institute, The University of Sydney - Westmead Hospital, Westmead Hospital - Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital - Centre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology-Institute of Clinical Pathology and Medical Research, NSW Health, NSW Health, Australian Red Cross, Australian Red Cross, Australian Red Cross, Australian Red Cross, University of New South Wales (UNSW), The University of Sydney - School of Medical Sciences, University of New South Wales (UNSW) - Kirby Institute and University of New South Wales (UNSW) - Kirby Institute
Downloads 103 (674,591)
Citation 1

Abstract:

Loading...

SARS-CoV-2, COVID-19, neutralisation, population immunity

3.

Emergence and Antibody Evasion of BQ and BA.2.75 SARS-CoV-2 Sublineages in the Face of Maturing Antibody Breadth at the Population Level

Number of pages: 19 Posted: 21 Dec 2022
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, Government of New South Wales - Serology and Virology Division (SAViD), University of Newcastle - Hunter Medical Research Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, The University of Sydney - Sydney Institute for Infectious Diseases, University of New South Wales (UNSW) - Kirby Institute, Government of New South Wales - Serology and Virology Division (SAViD), Government of New South Wales - Serology and Virology Division (SAViD), Government of New South Wales - Serology and Virology Division (SAViD), Government of New South Wales - Virology Research Laboratory, CSL Behring AG - Department of Bioanalytical Sciences, CSL Behring AG - Department of Bioanalytical Sciences, CSL Behring AG, CSL Behring AG, CSL Behring AG, Government of New South Wales - Virology Research Laboratory, CSL Behring AG - Department of Bioanalytical Sciences, Government of New South Wales - Serology and Virology Division (SAViD), Government of New South Wales - Virology Research Laboratory, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Royal Prince Alfred Hospital, The University of Sydney - Royal Prince Alfred Hospital, The University of Sydney - Royal Prince Alfred Hospital, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Royal Prince Alfred Hospital, The University of Sydney - Westmead Institute for Medical Research, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, The University of Sydney, Garvan Institute of Medical Research, University of Newcastle (Australia) - Viral Immunology and Respiratory Disease Group, St. Vincent's Hospital, University of New South Wales (UNSW) - Kirby Institute, St. Vincent's Hospital - Molecular Diagnostic Medicine Laboratory, Government of New South Wales - Virology Research Laboratory, The University of Sydney - School of Medical Sciences, The University of Sydney - Westmead Institute for Medical Research, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute and University of New South Wales (UNSW) - Kirby Institute
Downloads 90 (742,061)

Abstract:

Loading...

SARS-CoV-2Covid-19Neutralising antibodiesSotrovimabEvusheld